PBC
PFE icon

Pavion Blue Capital’s Pfizer PFE Stock Holding History

Pavion Blue Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,422
Closed -$208K – 115
2026
Q1 		$208K Buy
+7,422
New +$198K 0.09% 104
2025
Q4 		– Sell
-9,772
Closed -$249K – 109
2025
Q3 		$249K Sell
9,772
-15
-0.2% -$370 0.11% 93
2025
Q2 		$237K Buy
9,787
+788
+9% +$18.4K 0.11% 93
2025
Q1 		$228K Hold
8,999
– – 0.11% 91
2024
Q4 		$239K Hold
8,999
– – 0.11% 89
2024
Q3 		$260K Buy
+8,999
New +$263K 0.12% 85
2024
Q1 		– Sell
-6,987
Closed -$201K – 102
2023
Q4 		$201K Sell
6,987
-2,150
-24% -$65K 0.11% 96
2023
Q3 		$303K Buy
9,137
+268
+3% +$9.48K 0.18% 73
2023
Q2 		$325K Sell
8,869
-2,700
-23% -$105K 0.19% 72
2023
Q1 		$472K Sell
11,569
-300
-3% -$13K 0.29% 64
2022
Q4 		$608K Buy
11,869
+560
+5% +$26.8K 0.39% 55
2022
Q3 		$495K Hold
11,309
– – 0.35% 56
2022
Q2 		$593K Hold
11,309
– – 0.4% 54
2022
Q1 		$585K Buy
11,309
+588
+5% +$30.5K 0.34% 54
2021
Q4 		$633K Sell
10,721
-200
-2% -$9.91K 0.37% 54
2021
Q3 		$470K Hold
10,921
– – 0.29% 58
2021
Q2 		$428K Sell
10,921
-161
-1% -$6.26K 0.26% 60
2021
Q1 		$402K Hold
11,082
– – 0.26% 58
2020
Q4 		$408K Sell
11,082
-1,599
-13% -$58.7K 0.28% 59
2020
Q3 		$442K Buy
12,681
+993
+8% +$34.8K 0.34% 57
2020
Q2 		$363K Buy
11,688
+1,550
+15% +$52.7K 0.32% 55
2020
Q1 		$314K Buy
+10,138
New +$345K 0.33% 57

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pavion Blue Capital's PFE Position: Q2 2026 in Review

Pavion Blue Capital sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,422 shares — an estimated $208K sold.

Pavion Blue Capital first reported a position in PFE in Q1 2020 and held it in 22 quarters. The position peaked at $633K in Q4 2021. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Pavion Blue Capital reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Pavion Blue Capital sold 7,422 Pfizer shares in Q2 2026, an estimated $208K.
  • Pavion Blue Capital first reported a position in Pfizer in Q1 2020 and held it in 22 quarters.
  • Pavion Blue Capital's Pfizer position peaked at $633K in Q4 2021.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Pavion Blue Capital's 13F filing for Q2 2026, filed 7 Aug 2026.